Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-α) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . A method for the treatment of inflammatory diseases and conditions induced by or associated with excessive production of TNF-α and/or IL-1, which comprises administering to a subject a therapeutically effective amount of a compound of formula I or a pharmacologically acceptable salt or hydrate thereof:
wherein
x represents CH 2 , or a heteroatom selected from the group consisting of O, S, S(═O), S(═O) 2 or NR 13
wherein R 13 is hydrogen, C 1-6 alkyl, C 1-6 alkylcarbonyl, arylcarbonyl, C 1-6 alkylsulfonyl, or arylsulfonyl;
each R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 independently represents hydrogen, fluoro, chloro, bromo; or C 1 -C 7 alkyl, C 2 -C 7 alkenyl; monocyclic or bicyclic aryl group having from 6 to 10 carbon atoms and alternating double bonds between carbon atoms and said aryl group can be unsubstituted or substituted with fluoro, chloro, bromo, hydroxy, C 1 -C 7 alkyl, C 1 -C 7 alkoxy, aryloxy, wherein aryl has the meaning as defined above, C 1 -C 7 alkylthio, arylthio wherein aryl has the meaning as defined above, C 1 -C 7 alkylsulfonyl, cyano, or amino; C 1 -C 7 mono or di-C 1 -C 7 substituted amino, heteroaryl which is a monocyclic or bicyclic aromatic hydrocarbon containing at least one heteroatom selected from O, S or N optionally said heteroaryl can be unsubstituted or substituted with fluoro, chloro, bromo, CF 3 , methyl, ethyl or propyl; or halomethyl, hydroxy, C 1 -C 7 alkoxy, aryloxy wherein aryl has the meaning as defined above, C 1 -C 7 alkylthio, arylthio wherein aryl has the meaning as defined above, C 1 -C 7 alkylsulfonyl, cyano, amino, C 1 -C 7 mono- or di-C 1 -C 7 substituted amino, C 1 -C 7 hydroxycarbonyl, C 1 -C 7 alkanoyloxycarbonyl, carbamoyl, mono-N-(C 1 -C 7 )alkylcarbamoyl, di-N,N-(C 1 -C 7 )alkylcarbamoyl, C 1 -C 7 alkyloxycarbonyl, aryloxycarbonyl, C 1 -C 7 alkylcarbonyl, arylcarbonyl;
R 10 represents C 2 -C 15 alkyl, C 2 -C 15 alkenyl, C 2 -C 15 alkynyl, aryl or heteroaryl wherein aryl and heteroaryl have the meaning as defined above, C 1 -C 15 haloalkyl, C 1 -C 15 hydroxyalkyl, C 1 -C 15 alkyloxy, C 1 -C 15 alkylthio, C 3 -C 15 alkylcarbonyl, C 2 -C 15 hydroxycarbonyl, C 3 -C 15 alkyloxycarbonyl, C 1 -C 15 alkylsulfonyl, arylsulfonyl or C 1 -C 15 alkylarylsulfonyl wherein aryl has the meaning as defined above, CH═CHCH 2 OH, CH═CHCH 2 O(CH 2 ) n -A, or C 1 -C 15 alkylamino represented by the formula
(CH 2 )n-A
wherein
n is an integer from 1 to 15, optionally one or more methylene groups can be substituted with an oxygen or sulphur atom A represents saturated or unsaturated a five- or six-membered ring having from one to three heteroatoms selected from the group consisting of O, S, N or combinations thereof, or a group of the formula
wherein
R 11 and R 12 independently represent hydrogen, C 1 -C 7 alkyl, C 2 -C 7 alkenyl, C 2 -C 7 alkynyl, aryl or heteroaryl wherein aryl and heteroaryl have the meaning as defined above, or a saturated or unsaturated five- or six-membered ring having from one to three heteroatoms selected from the group consisting of O, S, N or combinations thereof.
17 . The method of claim 16 wherein R 10 represents CH 2 OH, CH═CHCH 2 OH or CH 2 CH 2 CH 2 OH.
18 . The method of claim 16 wherein R 10 represents (CH 2 ) n A, CH 2 O(CH 2 ) n -A, CH═CHCH 2 O(CH 2 ) n -A or CH 2 CH 2 CH 2 O(CH 2 ) n -A.
19 . The method of claim 16 wherein A represents morpholine-4-yl, piperidine-1-yl or pyrrolidine-1-yl.
20 . The method of claim 16 wherein A represents
wherein R 11 and R 12 are as defined in claim 16 .
21 . The method of claim 16 wherein R 11 and R 12 represent H, —CH 3 or —CH 2 CH 3 .
22 . The method of claim 16 wherein R 2 represents H, SCH 3 , F, Cl, Br or CH 3 .
23 . The method of claim 16 wherein R 3 represents H, OCH 3 , F, Cl, Br, CF 3 or CH 3 .
24 . The method of claim 16 wherein R 4 represents H, F, Cl or CH 3 .
25 . The method of claim 16 wherein R 6 represents H, F or Cl.
26 . The method according to claim 16 wherein R 10 represents C 1 -C 15 hydroxyalkyl, or C 2 -C 15 alkylamino represented by the formula
(CH 2 ) n -A.
27 . The method of claim 26 wherein said heteroaryl group is selected from the group consisting of thiophene, pyrrole, imidazole, pyridine, oxazole, thiazole, pyrazole, tetrazole, pyrimidine, pyrazine and triazine.
28 . The method of claim 16 wherein said heteroaryl group is selected from the group consisting of thiophene, pyrrole, imidazole, pyridine, oxazole, thiazole, pyrazole, tetrazole, pyrimidine, pyrazine and triazine.
29 . The method of claim 16 wherein the compound of formula I is selected from the group consisting of:
dimethyl-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine hydrochloride,
dimethyl-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine hydrochloride,
4-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,
[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine,
4-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,
1-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,
1-[2-(9-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
[3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,
[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine,
4-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,
1-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,
1-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
[3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(11-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,
1-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,
1-[2-(11-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
[3-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine, dimethyl-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine hydrochloride,
4-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine,
1-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(10-trifluoromethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine,
[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
1-[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(10-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
[3-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
1-[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
[2-(10-bromo-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[3-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
1-[2-(9,11-dimethyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-morpholine hydrochloride,
1-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine hydrochloride,
1-[2-(10,11-dichloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine hydrochloride,
[3-(9-chloro-11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-dimethyl-amine hydrochloride,
[2-(9-chloro-11-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine hydrochloride,
4-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-but-3-ene-2-one,
4-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-but-3-ene-2-one,
3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-acrylic acid,
3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propionic acid,
3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,
3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,
N,N-dimethyl-[3-(11-methylsulfanyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(11-methylsulfanyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
N,N-dimethyl-[3-(10-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(10-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
N,N-dimethyl-[3-(11-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(11-methyl-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
N,N-dimethyl-[3-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
1-(2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-piperidine,
1-(2-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-pyrrolidine,
3-(10-methoxy-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine,
N,N-dimethyl-[3-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
3-(6-chloro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[3-(10-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(10-fluoro-1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
[2-(3-dimethylamino-propoxymethyl)-1-thia-8-aza-dibenzo[e,h]azulene-8-yl)-phenyl-methanon,
[2-(2-dimethylamino-ethoxymethyl)-1-thia-8-aza-dibenzo[e,h]azulene-8-yl)-phenyl-methanon,
N,N-dimethyl-[3-(8H-1-thia-8-aza-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N,N-dimethyl-[2-(8H-1-thia-8-aza-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
[3-(11-fluoro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propylamine hydrochloride,
[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy]-propylamine,
N,N-dimethyl-{3-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propyloxy]-propyl}-amine,
N,N-dimethyl-{2-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-yl)-propyloxy]-ethyl}-amine,
N,N-dimethyl-{3-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-propyloxy]-propyl}-amine,
N,N-dimethyl-{2-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-propyloxy]-ethyl}-amine,
N,N-dimethyl-{3-(8H-1-thia-dibenzo[e,h]azulene-2-yl)-methoxy]-propyl}-amine,
N,N-dimethyl-{2-(8H-1-thia-dibenzo[e,h]azulene-2-yl)-methoxy]-ethyl}-amine,
N,N-dimethyl-{3-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-allyloxy]-propyl}-amine,
N,N-dimethyl-{2-[3-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-allyloxy]-ethyl}-amine,
N-methyl-[3-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N-methyl-[2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-amine,
N-methyl-[3-(8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
N-methyl-[3-(1,8-dithia-dibenzo[e,h]azulene-2-ylmethoxy)-propyl]-amine,
2-bromomethyl-1,8-dithia-dibenzo[e,h]azulene, and
2-(1,8-dithia-dibenzo[e,h]azulene-2-yl)-ethylamine, and salts and hydrates thereof.
30 . The method of claim 16 wherein the compound of formula I is [2-(11-chloro-8-oxa-1-thia-dibenzo[e,h]azulene-2-ylmethoxy)-ethyl]-dimethyl-amine.